Nisa Investment Advisors’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$497 Sell
115
-27
-19% -$118 ﹤0.01% 2946
2026
Q1
$545 Buy
+142
New +$582 ﹤0.01% 2854
2025
Q4
Sell
-72
Closed -$1.02K 3048
2025
Q3
$1.02K Sell
72
-410
-85% -$6.39K ﹤0.01% 2742
2025
Q2
$9.26K Buy
+482
New +$7.52K ﹤0.01% 2299
2024
Q3
Sell
-53
Closed -$3.03K 3018
2024
Q2
$3.03K Buy
53
+13
+33% +$637 ﹤0.01% 2330
2024
Q1
$1.34K Sell
40
-546
-93% -$27.6K ﹤0.01% 2308
2023
Q4
$47.6K Buy
586
+545
+1,329% +$44.3K ﹤0.01% 1652
2023
Q3
$6.75K Sell
41
-131
-76% -$30.9K ﹤0.01% 2244
2023
Q2
$56.3K Buy
172
+32
+23% +$9.76K ﹤0.01% 1716
2023
Q1
$39K Hold
140
﹤0.01% 1791
2022
Q4
$54K Hold
140
﹤0.01% 1739
2022
Q3
$33K Buy
140
+3
+2% +$803 ﹤0.01% 1899
2022
Q2
$31K Buy
137
+80
+140% +$34.4K ﹤0.01% 1900
2022
Q1
$39K Sell
57
-44
-44% -$26.5K ﹤0.01% 1907
2021
Q4
$57K Sell
101
-80
-44% -$59.2K ﹤0.01% 1695
2021
Q3
$134K Buy
181
+146
+417% +$99.5K ﹤0.01% 1569
2021
Q2
$26K Buy
+35
New +$26.8K ﹤0.01% 2086

Other funds holding OM

Nisa Investment Advisors's OM Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Outset Medical (OM) stake by 19% in Q2 2026, selling an estimated $118 and leaving 115 shares worth $497. The position accounts for ﹤0.01% of the portfolio, ranked #2946.

Nisa Investment Advisors first reported a position in OM in Q2 2021 and has held it in 17 quarters since. The position peaked at $134K in Q3 2021. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Nisa Investment Advisors held 115 shares of Outset Medical worth $497 as of Q2 2026.
  • Nisa Investment Advisors sold 27 Outset Medical shares in Q2 2026, an estimated $118.
  • Outset Medical made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2946 holding.
  • Nisa Investment Advisors first reported a position in Outset Medical in Q2 2021 and has held it in 17 quarters since.
  • Nisa Investment Advisors's Outset Medical position peaked at $134K in Q3 2021.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.